MGALIN-NT

Composition:Each tablet contains: Nortriptyline 10mg Pregabalin 75mg Methylcobalamin (MCB) 1500mcg

DRUGNEURO
CompositionComposition:Each tablet contains: Nortriptyline 10mg Pregabalin 75mg Methylcobalamin (MCB) 1500mcg
PackingALU ALU WITH CARTON - 10*10Pack Style: ALU ALU
MRP₹188

Product Overview

MGALIN-NT is an advanced triple-combination neurotropic formulation designed for the comprehensive management of severe chronic neuropathic pain. By combining a gabapentinoid, a tricyclic neuro-modulator, and an essential nerve-rejuvenating vitamin, it provides rapid relief from persistent nerve pain.

Indications

This combination tablet is indicated for the treatment of:

  • Diabetic Peripheral Neuropathy: Relieves burning, tingling, and lancinating pain in the extremities.
  • Postherpetic Neuralgia: Manages persistent, debilitating nerve pain following herpes zoster infections.
  • Fibromyalgia: Controls widespread musculoskeletal pain and associated neurological distress.
  • Spinal Nerve Compression Pain: Alleviates radiculopathy secondary to disc herniation or spinal stenosis.

Dosage & Administration

The standard adult dose is one tablet taken orally once daily, preferably at bedtime to minimize daytime drowsiness. The dose may be adjusted by a physician based on the patient's clinical response and renal function profiles.

Adverse Effects

Commonly observed side effects are usually dose-dependent and include:

  • Dizziness, somnolence, and ataxia
  • Dryness of the mouth and blurred vision
  • Mild peripheral edema or constipation
View Complete Medical Information

Contraindications

Contraindicated in patients with a history of hypersensitivity to pregabalin, nortriptyline, or methylcobalamin. Do not use during the acute recovery phase following a myocardial infarction or concurrently with monoamine oxidase inhibitors (MAOIs).

Warnings & Precautions

Patients should be monitored closely for suicidal thoughts, clinical worsening of depression, or sudden behavioral changes, particularly during the initial weeks of therapy. Taper the dose gradually over at least one week when discontinuing treatment to avoid withdrawal symptoms. Use with caution in patients with severe renal impairment, congestive heart failure, or urinary retention.

Drug Interactions

Concomitant administration with central nervous system depressants, sedatives, or alcohol can cause severe additive somnolence and respiratory depression. Serious adverse reactions may occur if co-administered with MAO inhibitors or drugs that significantly prolong the QT interval.

Storage Instructions

Store below 30°C in a dry place. Protect from high humidity and keep out of the reach of children.

MGALIN-NT
Click to enlarge
PCD Franchise Opportunity

Request This Product

  • WHO-GMP Certified Formulations
  • Monopoly Rights Available
  • Get bulk pricing & MOQ
Enquire NowWhatsApp Us Now

+91 9689237122 · replies within hours

Interested in this product?

Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.

Need something? Chat with us!